[1]朱 艳,周 琴,安 洁,等.脂联素基因单核苷酸多态性与多囊卵巢综合征伴胰岛素抵抗的关系研究[J].医学信息,2020,33(22):87-91.[doi:10.3969/j.issn.1006-1959.2020.22.025]
　ZHU Yan,ZHOU Qin,AN Jie,et al.Study on the Relationship Between Adiponectin Gene Single Nucleotide Polymorphism and Polycystic Ovary Syndrome with Insulin Resistance[J].Medical Information,2020,33(22):87-91.[doi:10.3969/j.issn.1006-1959.2020.22.025]
点击复制

脂联素基因单核苷酸多态性与多囊卵巢综合征伴胰岛素抵抗的关系研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年22期
页码:
87-91
栏目:
论著
出版日期:
2020-11-15

文章信息/Info

Title:
Study on the Relationship Between Adiponectin Gene Single Nucleotide Polymorphism and Polycystic Ovary Syndrome with Insulin Resistance
文章编号:
1006-1959（2020）22-0087-05
作者:
朱 艳; 周 琴; 安 洁; 等
（昆山市中医医院妇科，江苏 昆山 215300）
Author(s):
ZHU Yan; ZHOU Qin; AN Jie; ZHANG Jian-zhi; et al
(Department of Gynecology,Kunshan Traditional Chinese Medicine Hospital,Kunshan 215300,Jiangsu,China)
关键词:
多囊卵巢综合征; 胰岛素抵抗; 脂联素浓度; 脂联素基因多态性; +276G/T（rs1501299）; +45T/G（rs2241766）
Keywords:
Polycystic ovary syndrome; Insulin resistance; Adiponectin concentration; Adiponectin gene polymorphism; +276G/T (rs1501299); +45T/G (rs2241766)
分类号:
R711.75
DOI:
10.3969/j.issn.1006-1959.2020.22.025
文献标志码:
A
摘要:
目的 探讨脂联素浓度、脂联素基因第2外显子的+45T/G（rs2241766）和第2内含子的+276G/T（rs1501299）两个多态性位点、PCOS伴胰岛素抵抗（IR）三者的关系，并探讨其是否可以为临床诊疗及预后提供数据依据。方法 收集2017年1月~2019年1月昆山市中医医院就诊年龄在20~35岁，符合鹿特丹标准的PCOS患者和正常人各100例。采用分子生物学的方法对脂联素基因进行分型。比较两组临床资料、脂联素浓度及脂联素基因分型。结果 PCOS组的雄激素、雌激素、促黄体生成素、胰岛素、胆固醇、甘油三酯、血糖高于对照组（P＜0.05）；对照组的促卵泡生成素、泌乳素低于 PCOS 组（P＜0.05）；PCOS组脂联素水平和IR存在线性关系（P＜0.05）；对照组脂联素基因多态位点+276G/T（ rs1501299）不符合 HWE 遗传定律，组间无法比较；两组+45T/G（rs2241766）位点的基因型（TT、TG、GG）频率分布比较，差异无统计学意义（P＞0.05），此位点基因型频率与脂联素浓度、HOMA-IR进行关联分析，差异无统计学意义（P＞0.05）。结论 PCOS 组的脂联素水平和IR呈负相关，脂联素基因+45T/G（rs2241766）位点基因分型与PCOS伴IR患者无显著关系，可能不参与 PCOS 发生。
Abstract:
Objective To investigate the adiponectin concentration, the +45T/G (rs2241766) and +276G/T (rs1501299) polymorphisms in the second exon of the adiponectin gene, and PCOS with insulin resistance (IR) The relationship between the three and explore whether it can provide data for clinical diagnosis and treatment and prognosis.Methods From January 2017 to January 2019, 100 PCOS patients and 100 normal people who were 20-35 years old and met the Rotterdam standard were collected from Kunshan Traditional Chinese Medicine Hospital. Adiponectin genes were typed using molecular biology methods. The clinical data, adiponectin concentration and genotype of adiponectin were compared between the two groups. Results Androgen, estrogen, luteinizing hormone, insulin, cholesterol, triglyceride, and blood sugar in the PCOS group were higher than those in the control group, the difference was statistically significant (P<0.05); the control group had low follicle stimulating hormone and prolactin the PCOS group, the difference was statistically significant (P＜0.05); there was a linear relationship between adiponectin levels and IR in the PCOS group (P＜0.05); Adiponectin gene polymorphic site +276G/T (rs1501299) in the control group does not comply with the HWE genetic law and cannot be compared between groups; the frequency of genotypes (TT, TG, GG) at +45T/G (rs2241766) sites in the two groups the distribution comparison showed no statistically significant difference (P>0.05). The correlation analysis between the genotype frequency of this locus and the adiponectin concentration and HOMA-IR showed that the difference was not statistically significant (P>0.05).Conclusion The level of adiponectin in the PCOS group is negatively correlated with IR. The genotyping of adiponectin gene +45T/G (rs2241766) has no significant relationship with patients with PCOS with IR, and may not be involved in the occurrence of PCOS.

参考文献/References:

[1]Azziz R,Carmina E,Chen Z,et al.Polycystic ovary syndrome[J].Nat Rev Dis Primers,2016(2):16057.[2]Thackray VG.Sex,Microbes,and Polycystic Ovary Syndrome[J].Trends Endocrinol Metab,2019,30(1):54-65.[3]Van Berendoncks AM,Stensvold D,Garnier A,et al.Disturbed adiponectin-AMPK system in skeletal muscle of patients with metabolic syndrome[J].Eur J Prev Cardiol,2015,22(2):203-205.[4]Orio F Jr,Palomba S,Cascella T,et al.Adiponectin levels in women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2003,88(6):2619-2623.[5]Ranjzad F,Mahmoudi T,Irani Shemirani A,et al.A common variant in the adiponectin gene and polycystic ovary syndrome risk[J].Mol Biol Rep,2012,39(3):2313-2319.[6]Li L,Yun JH,Lee JH,et al.Association study of +45G15G(T/G)and+276(G/T)polymorphisms in the adiponectin gene in patients with polycystic ovary syndrome[J].Int J Mol Med,2011,27(2):283-287.[7]Tiongco RE,Cabrera FJ,Clemente B,et al.G276T polymorphism in the ADIPOQ gene is associated with a reduced risk of polycystic ovarian syndrome:A meta-analysis of Asian population[J].Taiwan J Obstet Gynecol,2019,58(3):409-416.[8]Xita N,Georgiou I,Chatzikyriakidou A,et al.Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome[J].Clin Chem,2005,51(2):416-423.[9]Naz MSG,Tehrani FR,Majd HA,et al.The prevalence of polycystic ovary syndrome in adolescents:A systematic review and meta-analysis[J].Int J Reprod Biomed,2019,17(8):533-542.[10]Brown MA,Chang RJ.Polycystic ovary syndrome:clinical and imaging features[J].Ultrasound Q,2007,23(4):233-238.[11]Piltonen TT.Polycystic ovary syndrome:Endometrial markers[J].Best Pract Res Clin Obstet Gynaecol,2016(37):66-79.[12]Lei L,Li K,Li L,et al.Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin[J].Nutr Metab (Lond),2017(14):53.[13]Li M,Yang M,Zhou X,et al.Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2015,100(4):1485-1493.[14]Messinis IE,Messini CI,Anifandis G,et al.Polycystic ovaries and obesity[J].Best Pract Res Clin Obstet Gynaecol,2015,29(4):479-488.[15]Vrbíková J,Dvoráková K,Hill M,et al.Determinants of circulating adiponectin in women with polycystic ovary syndrome[J].Gynecol Obstet Invest,2005,60(3):155-161.[16]Liu X,Zhang J,Li Y,et al.[On the relationship between serum total adiponectin and insulin resistance in polycystic ovary syndrome][J].Journal of Biomedical Engineering,2010,27(3):636-640. [17]Ramos-Lopez O,Riezu-Boj JI,Milagro FI,et al.Interplay of an Obesity-Based Genetic Risk Score with Dietary and Endocrine Factors on Insulin Resistance[J].Nutrients,2019,12(1):33.[18]Ozegowska K,Bartkowiak-Wieczorek J,Bogacz A,et al.Relationship between adipocytokines and angiotensin converting enzyme gene insertion/deletion polymorphism in lean women with and without polycystic ovary syndrome[J].Gynecol Endocrinol,2020,36(6):496-500. [19]Liu M,Liu F.Regulation of adiponectin multimerization, signaling and function[J].Best Pract Res Clin Endocrinol Metab,2014,28(1):25-31. [20]Alfaqih MA,Khader YS,Al-Dwairi AN,et al.Lower Levels of Serum Adiponectin and the T Allele of rs1501299 of the ADIPOQ Gene Are Protective against Polycystic Ovarian Syndrome in Jordan[J].Korean J Fam Med,2018,39(2):108-113.[21]张文娟，吴兴国，丁明德，等.脂联素基因多态性与多囊卵巢综合征发病关系的病例对照研究[J].中华妇产科杂志,2015, 50（11）:825-829.[22]Meigs JB,Dupuis J,Herbert AG,et al.The insulin gene variable number tandem repeat and risk of type 2 diabetes in a population-based sample of families and unrelated men and women[J].J Clin Endocrinol Metab,2005,90(2):1137-1143.

相似文献/References:

[1]吕 宁,徐 昕,黄 永,等.公安民警皮肤软纤维瘤与代谢综合征危险因素相关性研究[J].医学信息,2018,31(10):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
　LV Ning,XU Xin,HUANG Yong,et al.Correlative Study on Skin Soft Fibroma and Risk Factors of Metabolic Syndrome in Public Security Police[J].Medical Information,2018,31(22):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
[2]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(22):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[3]崔姗姗,刘 英,江 霞.非酒精性脂肪性肝病与胰岛素抵抗的研究进展[J].医学信息,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
　CUI Shan-shan,LIU Ying,JIANG Xia.Research Progress on Non-alcoholic Fatty Liver Disease and Insulin Resistance[J].Medical Information,2022,35(22):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
[4]何 丽.应激性高血糖与急性心肌梗死的机制研究[J].医学信息,2022,35(10):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
　HE Li.Mechanism of Stress Hyperglycemia and Acute Myocardial Infarction[J].Medical Information,2022,35(22):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
[5]袁 奔,潘 伟,罗淑红,等.体重指数对多囊卵巢综合征患者 人工授精妊娠结局影响[J].医学信息,2018,31(12):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
　YUAN Ben,PAN Wei,LUO Shu-hong,et al.Effects of Body Mass Index on the Outcome of Artificial Insemination in Patients with Polycystic Ovary Syndrome[J].Medical Information,2018,31(22):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
[6]罗红财,沈 颖,黄莉珊,等.基于温肾助阳、暖宫温胞改善卵巢功能异常的机制分析[J].医学信息,2022,35(11):172.[doi:10.3969/j.issn.1006-1959.2022.11.046]
　LUO Hong-cai,SHEN Ying,HUANG Li-shan,et al.The Mechanism Analysis of Improve Symptoms Related to Ovarian Dysfunction Based on Warming Kidney and Helping Yang,Warming Baogong[J].Medical Information,2022,35(22):172.[doi:10.3969/j.issn.1006-1959.2022.11.046]
[7]曾利文,陈 静,张 晔,等.多囊卵巢综合征患者的糖代谢特点分析[J].医学信息,2019,32(02):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
　ZENG Li-wen,CHEN Jing,ZHANG Ye,et al.Analysis of Characteristics of Glucose Metabolism in Patients with Polycystic Ovarian Syndrome[J].Medical Information,2019,32(22):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
[8]李德君,李慧君.来曲唑联合苍附导痰汤治疗多囊卵巢综合征不孕症患者的 临床观察[J].医学信息,2018,31(17):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
　LI De-jun,LI Hui-jun.Clinical Observation of Letrozole Combined with Cangfu Daotan Decoction in the Treatment of Infertility Patients with Polycystic Ovary Syndrome[J].Medical Information,2018,31(22):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
[9]谢小莉,李 燕,霍 敏,等.老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、 白介素-6的相关性研究[J].医学信息,2019,32(15):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
　XIE Xiao-li,LI Yan,HUO Min,et al.Correlation between Mild Cognitive Impairment and Insulin Resistance and Interleukin-6 in Elderly Type 2 Diabetic Patients[J].Medical Information,2019,32(22):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
[10]左俊芳,刘沙沙,崔洪艳.妊娠期糖尿病高危因素及预防措施研究[J].医学信息,2022,35(17):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
　ZUO Jun-fang,LIU Sha-sha,CUI Hong-yan.Study on High Risk Factors and Preventive Measures of Gestational Diabetes Mellitus[J].Medical Information,2022,35(22):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
[11]袁 瑞,余亚莉.吡格列酮二甲双胍片治疗胰岛素抵抗型多囊卵巢综合征患者的疗效[J].医学信息,2021,34(01):158.[doi:10.3969/j.issn.1006-1959.2021.01.043]
　YUAN Rui,YU Ya-li.Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets in the Treatment of Patients with Insulin-resistant Polycystic Ovary Syndrome[J].Medical Information,2021,34(22):158.[doi:10.3969/j.issn.1006-1959.2021.01.043]
[12]陈 丽,郝丽娟.多囊卵巢综合征患者腹型肥胖、高雄、胰岛素抵抗及脂代谢的相关性分析[J].医学信息,2022,35(12):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
　CHEN Li,HAO Li-juan.Correlation of Abdominal Obesity, Hyperandrogenism, Insulin Resistance and Lipid Metabolism in Patients with Polycystic Ovary Syndrome[J].Medical Information,2022,35(22):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
[13]牛佳莉,陆美茵,刘 斌.实验室检查指标对于多囊卵巢综合征患者排卵障碍的筛查效能[J].医学信息,2023,36(03):93.[doi:10.3969/j.issn.1006-1959.2023.03.019]
　NIU Jia-li,LU Mei-yin,LIU Bin.Efficacy of Laboratory Test Indicators for Screening Ovulation Disorders in Patients with Polycystic Ovary Syndrome[J].Medical Information,2023,36(22):93.[doi:10.3969/j.issn.1006-1959.2023.03.019]

更新日期/Last Update: 1900-01-01